Notifications
Back
Notification settings
Back
More
Post notifications
Post reactions
Be notified when someone leaves a comment or a reply to your post or comment.
Updates and news
Stay ahead of important updates and news from the site.
Alarm
My account
Sign out
Sign-in required.
Sign in
About Us
Greetings
Our Vision
Our Platform
Our Partners
Pharmacometrics
What is M&S?
Methods
Benefits
Our Projects
Services
Early Phase Clinical Trials
Pharmacometric Analysis
News
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
Contact Us
Our Location
Talk to Consultants
Matching Platform
Close
Site logo
About Us
Greetings
Our Vision
Our Platform
Our Partners
Pharmacometrics
What is M&S?
Methods
Benefits
Our Projects
Services
Early Phase Clinical Trials
Pharmacometric Analysis
News
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
Contact Us
Our Location
Talk to Consultants
Matching Platform
MENU
Site logo
About Us
Pharmacometrics
Services
News
Contact Us
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
Check out our press releases, events,
and learning sessions!
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
Press Releases
Updates and news
[Q-fitter's News] 신약개발, 약동학-약력학 모델링 중요성 커져 [2020.11.06]
0
0
관리자
10 May 2021
Views
1306
Updates and news
[Q-fitter's News] 큐피터, 전상일 신임대표 선임 [2021.04.07]
0
0
관리자
7 Apr 2021
Views
896
Updates and news
[Q-fitter's News] 애임스바이오사이언스·큐피터, 신약연구개발 협력 MOU [2021.03.24]
0
0
관리자
29 Mar 2021
Views
931
Updates and news
[Q-fitter's News] 큐피터, 전상일 이사 상무 승진 [2020.07.13]
0
0
관리자
14 Jul 2020
Views
1541
Updates and news
[Q-fitter's News] 임상개발 계획과 초기임상 [2020.04.16]
0
0
관리자
21 Apr 2020
Views
2595
Updates and news
[Q-fitter's News] 국내 제약/바이오사의 후기임상시험 실패, 정말 문제일까?
0
0
관리자
31 Mar 2020
Views
2443
Updates and news
[Q-fitter's News] 혁신신약 Quick-Win전략 V "데이터를 지식화하라" [2020.02.05]
0
0
관리자
7 Feb 2020
Views
2458
Updates and news
[Q-fitter's News] 혁신신약 Quick-Win 전략 IV "비임상데이터, 개발 밑천" [2020.01.16]
0
0
관리자
16 Jan 2020
Views
2493
Previous
1
2
3
4
Next
